385 results on '"Tan, Darrell H S"'
Search Results
2. Correlates of Breakthrough SARS-CoV-2 Infections in People with HIV: Results from the CIHR CTN 328 Study
3. Non-AIDS-defining comorbidities impact health related quality of life among older adults living with HIV
4. PrEP-related stigma and PrEP use among gay, bisexual and other men who have sex with men in Ontario and British Columbia, Canada
5. A national recruitment strategy for HIV-serodiscordant partners living in Canada for the Positive Plus One study: a mixed-methods study
6. Monkeypox-Associated Disciform Keratitis
7. Reported Side Effects and Adherence of Daily HIV Pre-Exposure Prophylaxis Users in Ontario, Canada: An Analysis of the Ontario Pre-Exposure Prophylaxis Cohort Study.
8. HIV pre-exposure prophylaxis and opportunities for vaccination against hepatitis A virus, hepatitis B virus and human papillomavirus: an analysis of the Ontario PrEP cohort study.
9. Prevalence of HIV and sexually transmitted and blood-borne infections, and related preventive and risk behaviours, among gay, bisexual and other men who have sex with men in Montreal, Toronto and Vancouver: results from the Engage Study
10. Preferences regarding emerging HIV prevention technologies among Toronto men who have sex with men: a discrete choice experiment
11. High prevalence of syndemic health problems in patients seeking post-exposure prophylaxis for sexual exposures to HIV
12. Longitudinal Analysis of Mpox Virus DNA Detectability From Multiple Specimen Types During Acute Illness: A Cohort Study
13. Initiation of long-acting cabotegravir plus rilpivirine as direct-to-injection or with an oral lead-in in adults with HIV-1 infection: week 124 results of the open-label phase 3 FLAIR study
14. Can laboratory HIV and infectious syphilis data inform future pre-exposure prophylaxis use in women in Ontario, Canada?
15. Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial
16. Long-acting cabotegravir plus rilpivirine for treatment in adults with HIV-1 infection: 96-week results of the randomised, open-label, phase 3 FLAIR study
17. Trends in HIV pre-exposure prophylaxis uptake in Ontario, Canada, and impact of policy changes: a population-based analysis of projected pharmacy data (2015–2018)
18. Preparing for Mpox Resurgence: Surveillance Lessons From Outbreaks in Toronto, Canada.
19. End of selection criteria based on sexual orientation: An international symposium on alternatives to donation deferral.
20. 893. Myocarditis and Pericarditis as a Complication of Mpox: An International Case Series and Literature Review
21. Brief Report: Outcomes of Individuals Using HIV Postexposure Prophylaxis-In-Pocket (“PIP”) for Low-Frequency, High-Risk Exposures in Toronto, Canada
22. Preferences regarding emerging HIV prevention technologies among Toronto men who have sex with men: a discrete choice experiment
23. Post-exposure prophylaxis against SARS-CoV-2 in close contacts of confirmed COVID-19 cases (CORIPREV): study protocol for a cluster-randomized trial
24. Human Immunodeficiency Virus Treatment Attitudes and Bacterial Sexually Transmitted Infections Among Gay and Bisexual Men.
25. 'It's not as good as the face‐to‐face contact': A sociomaterialist analysis of the use of virtual care among Canadian gay, bisexual and queer men during the COVID‐19 pandemic.
26. Interest in Hypothetical Preexposure Prophylaxis Against Herpes Simplex Virus: A Cross-Sectional Survey
27. Trends in the awareness, acceptability, and usage of HIV pre-exposure prophylaxis among at-risk men who have sex with men in Toronto
28. High Interest in Syphilis Pre- and Post-Exposure Prophylaxis Among Gay, Bisexual and Other Men Who Have Sex With Men in Vancouver and Toronto
29. ‘It’s not as good as the face‐to‐face contact’: A sociomaterialist analysis of the use of virtual care among Canadian gay, bisexual and queer men during the COVID‐19 pandemic
30. Moving fast but going slow: coordination challenges for trials of COVID-19 post-exposure prophylaxis
31. Protecting Frontline Health Care Workers from COVID-19 with Hydroxychloroquine Pre-exposure Prophylaxis: A structured summary of a study protocol for a randomised placebo-controlled multisite trial in Toronto, Canada
32. Treatment‐emergent reverse transcriptase resistance during antiretroviral therapy with bictegravir, tenofovir alafenamide, and emtricitabine: A case series.
33. HIV pre-exposure prophylaxis: It is time to consider harm reduction care for adolescents in Canada.
34. Antibody neutralization capacity after coronavirus disease 2019 vaccination in people with HIV in Canada.
35. Evidence of Nonrandom Mixing by Pre-exposure Prophylaxis Use Among Men Who Have Sex With Men Partnerships in Melbourne, 2016 to 2018
36. Correlates of Healthy Aging in Geriatric HIV (CHANGE HIV)—CTN 314
37. Vaccine Effectiveness Against 12-Month Incident and Persistent Anal Human Papillomavirus Infection Among Gay, Bisexual, and Other Men Who Have Sex With Men
38. The Need and Desire for Mental Health and Substance Use–Related Services Among Clients of Publicly Funded Sexually Transmitted Infection Clinics in Vancouver, Canada
39. Brief Report: Syphilis Coinfection Is Not Associated With an Increased Risk of Virologic Failure Among HIV-Positive Men Who Have Sex With Men on Antiretroviral Therapy
40. Sexually Transmitted Infections
41. Syndemic Factors and Lifetime Bidirectional Intimate Partner Violence Among Gay, Bisexual, and Other Sexual Minority Men.
42. Disclosure of HIV-serodiscordant relationships and association with viral suppression: results from the Positive Plus One study.
43. Environmental surface contamination with monkeypox virus in the ambulatory setting in Toronto, Canada
44. Intersecting HIV and mpox epidemics: more questions than answers
45. Atypical Clinical Presentation of Monkeypox Complicated by Myopericarditis
46. Selecting an Antiretroviral Regimen for Human Immunodeficiency Virus Postexposure Prophylaxis in the Occupational Setting
47. Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational postexposure prophylaxis
48. Considerations for Using the HIRI-MSM Screening Tool to Identify MSM Who Would Benefit Most From PrEP
49. A Randomized Controlled Pilot Trial of Valacyclovir for Attenuating Inflammation and Immune Activation in HIV/Herpes Simplex Virus 2–Coinfected Adults on Suppressive Antiretroviral Therapy
50. Gay, bisexual, and queer men's confidence in the Undetectable equals Untransmittable HIV prevention message: longitudinal qualitative analysis of the sexual decision-making of pre-exposure prophylaxis users over time.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.